Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,020.88
+16.530.82%
Number of Gainers:615
Number of Losers:390
Number of Flat:16
PE:- -
High:2,028.19
Open:2,004.58
Low:2,004.58
Close:2,004.35
Volume:6.06B
Turnover:742.41B
Market Cap:96.59T
Float Cap:90.42T

Loading ...

Amazon Adds Prime Delivery Option, Discounts Fulfillment Fees for Merchants

MT Newswires Live
·
Sep 24

Paychex, Inc. : Bmo Cuts Target Price to $113 from $118

THOMSON REUTERS
·
Sep 24

14th "Rhythm of the Copper Capital, Law Safeguards Business" Event Held in Tongling Economic Development Zone

Deep News
·
Sep 24

Musk Expands Business Empire Across the American Sun Belt with Massive Investments

Deep News
·
Sep 24

Lufax Resumes Hong Kong Trading After 20-Month Suspension, Market Value Reaches HK$11.2 Billion

Deep News
·
Sep 24

On Holding Ag : Bmo Raises Target Price to $33 from $28

THOMSON REUTERS
·
Sep 24

Bernstein Lifts Quanta to 'outperform' on Grid Expansion

Reuters
·
Sep 24

Merck Says Remigromig Meets Primary Endpoint in Pivotal Brunello Trial for Diabetic Macular Edema

Reuters
·
Sep 24

EssilorLuxottica's Smart Eyewear Launches with Meta Should Boost the Category

Dow Jones
·
Sep 24

Cal-Maine Foods, Inc. : Bmo Cuts Target Price to $75 from $83

THOMSON REUTERS
·
Sep 24

Eli Lilly - Onswik Kwikpen to be Available in U.S. in 500 Units/Ml and 1,000 Units/Ml Concentrations

THOMSON REUTERS
·
Sep 24

U.S. Food and Drug Administration (FDA) Approves Lilly's Onswik™ (Insulin Efsitora Alfa-Gobe), a Once-Weekly Basal Insulin Injection Treatment for Adults Living with Type 2 Diabetes

THOMSON REUTERS
·
Sep 24

Merck & Co - Higher Rates of Pdr, Vitreous Hemorrhage, and Discontinuations with Remigromig

THOMSON REUTERS
·
Sep 24

Merck’s Remigromig, a Tri-Specific Agonist of the Wingless-Related Integration Site (Wnt) Pathway, Met Primary Endpoint in the Pivotal Phase 2B/3 Brunello Study of Adults with Diabetic Macular Edema

THOMSON REUTERS
·
Sep 24

Merck & Co Inc: Both Doses of Remigromig were Generally Well Tolerated

THOMSON REUTERS
·
Sep 24

Merck & Co - Both Remigromig Doses Show Non-Inferiority to Ranibizumab at 52 Weeks

THOMSON REUTERS
·
Sep 24

BME Names Alliance Automotive CEO Franck Baduel to Supervisory Board

Reuters
·
Sep 24

Zhaoyang District Apple Industry Drives Rural Revitalization as 2025 Harvest Boosts Comprehensive Output Value to 13.5 Billion Yuan

Deep News
·
Sep 24

Amazon Launches New AI Product, Reflecting Industry-Wide Price Cuts

Deep News
·
Sep 24

Microsoft's Brad Smith Says AI Needs an Emergency Kill Switch

Deep News
·
Sep 24